logo
welcome
Reuters

Reuters

Sensodyne maker Haleon to raise stake in China JV

Reuters
Summary
Nutrition label

81% Informative

British consumer healthcare company Haleon plans to increase its stake in its Chinese joint venture to 88% from 55% .

Haleon will pay 4.47 billion yuan ( $637 million ) to buy the stake from partners Tianjin Pharmaceutical Group (TPG) An increasing number of Western firms are pulling back from China due to heightened geopolitical tensions and slowing economic growth.

VR Score

92

Informative language

97

Neutral language

87

Article tone

formal

Language

English

Language complexity

47

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links